0
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Large-Scale Production of Polyoma Middle T Antigen by Using Genetically Engineered Tumors

, , , , &
Pages 1795-1799 | Received 10 Dec 1984, Accepted 17 Apr 1985, Published online: 31 Mar 2023

LITERATURE CITED

  • Bolen, J., Thiele C. J., Israel M. A., Yonemoto W., Lipich L. A., and Brugge J. S.. 1984. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation. Cell 38:767–777.
  • Bolen, J. B., and Israel M. A.. 1985. Middle tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with pp60c-src. J. Virol. 53:114–119.
  • Brinster, R., Chen C., Warren R., Sarthy A., and Palmiter R.. 1982. Regulation of metallothionein-thymidine kinase fusion plasmids injected into mouse eggs. Nature (London) 296:39–42.
  • Carmichael, G. G., Schaffhausen B., Dorsky D. I., Oliver D. B., and Benjamin T. L.. 1982. Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation. Proc. Natl. Acad. Sci. U.S.A. 79:3579–3583.
  • Carmichael, G. G., Schaffhausen B. S., Mandel G., Liang T. J., and Benjamin T. L.. 1984. Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc. Natl. Acad. Sci. U.S.A. 81:679–683.
  • Copeland, N. G., and Cooper G. M.. 1979. Transfection by exogenous and endogenous murine retrovirus DNAs. Cell 16:347–356.
  • Courtneidge, S. A., and Smith A. E.. 1983. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature (London) 303:435–439.
  • Courtneidge, S. A., and Smith A. E.. 1984. The complex of polyoma virus middle-T antigen and pp60c-src. EMBO J. 3:585–591.
  • Eckhart, W., Hutchinson M. A., and Hunter T.. 1979. An activity phosphorylating tyrosine in polyoma T antigen im-munoprecipitates. Cell 18:925–933.
  • Feunteun, J., Sompayrac L., Fluck M., and Benjamin T.. 1976. Localization of gene functions in polyoma virus DNA. Proc. Natl. Acad. Sci. U.S.A. 73:4169–4173.
  • Graham, F. L., and van der Eb A. J.. 1973. A new technique for the assay of human adenovirus 5 DNA. J. Gen. Virol. 52:455–467.
  • Ito, Y. 1979. Polyoma virus-specific 55K protein isolated from plasma membrane of productively infected cells is virus coded and important for cell transformation. Virology 98:261–266.
  • Ito, Y., Spurr N., and Griffin B. E.. 1980. Middle T antigen as primary inducer of full expression of the phenotype of transformation by polyoma virus. J. Virol. 35:219–232.
  • Kamen, R., Favaloro J., Parker J., Treisman R., Lania L., Freid M., and Mellor A.. 1979. Comparison of polyoma virus transcription in productively infected mouse cells and transformed rodent cell lines. Cold Spring Harbor Symp. Quant. Biol. 44:63–75.
  • Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680–685.
  • Magnusson, G., and Berg P.. 1979. Construction and analysis of viable deletion mutants of polyoma virus. J. Virol. 32:523–529.
  • Morrissey, J. 1981. Silver stain for proteins: a modified procedure with enhanced uniform sensitivity. Anal. Biochem. 117:307–310.
  • Mulligan, R. C, and Berg P.. 1981. Selection for animal cells that express the Escherichia coli gene coding xanthine-guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci. U.S.A. 78:2072–2076.
  • Pavlakis, G. N., and Hamer D. H.. 1983. Regulation of a metallothionein-growth hormone hybrid gene in bovine papilloma virus. Proc. Natl. Acad. Sci. U.S.A. 80:397–401.
  • Rassoulzadegan, M., Cowie A., Carr A., Glaichenhaus N., Kamen R., and Cuzin F.. 1982. The roles of individual polyoma virus early proteins in oncogenic transformation. Nature (London) 300:713–718.
  • Roberts, T. M., and Lauer G. D.. 1979. Maximizing gene expression on a plasmid using recombination in vitro. Methods Enzymol. 68:473–481.
  • Schaffhausen, B. 1982. Transforming genes and gene products of polyoma and SV40. Crit. Rev. Biochem. 13:215–286.
  • Schaffhausen, B., and Benjamin T. L.. 1981. Comparison of phosphorylation of two polyoma virus middle T antigens in vivo and in vitro. J. Virol. 40:184–196.
  • Schaffhausen, B., and Benjamin T. L.. 1981. Protein kinase activity associated with polyoma virus middle T antigen. Cold Spring Harbor Conf. Cell Proliferation 8:1281–1298.
  • Schaffhausen, B., Benjamin T. L., Lodge J., Kaplan D., and Roberts T. M.. 1985. Expression of polyoma early gene products in E. coli. Nucleic Acids Res. 13:501–519.
  • Schaffhausen, B., Silver J., and Benjamin T.. 1978. Tumor antigen(s) in cells productively infected by wild type polyoma virus and mutant NG18. Proc. Natl. Acad. Sci. U.S.A. 75:79–83.
  • Schaffhausen, B. S., and Benjamin T. L.. 1979. Phosphorylation of polyoma T antigens. Cell 18:935–946.
  • Schaffhausen, B. S., Dorai H., Arakere G., and Benjamin T. L.. 1982. Polyoma virus middle T antigen: relationship to cell membranes and apparent lack of ATP-binding activity. Mol. Cell. Biol. 2:1187–1198.
  • Smith, A., Smith R., Griffin B., and Fried M.. 1979. Protein kinase activity associated with polyoma virus middle T antigen in vitro. Cell 18:915–924.
  • Templeton, D., and Eckhart W.. 1982. Mutation causing premature termination of the polyoma virus medium T antigen blocks cell transformation. J. Virol. 41:1014–1024.
  • Treisman, R., Novak U., Favaloro J., and Kamen R.. 1981. Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature (London) 292:595–600.
  • Walter, G., Hutchinson M. A., Hunter T., and Eckhart W.. 1982. Purification of polyoma virus medium-size tumor antigen by immunoaffinity chromatography. Proc. Natl. Acad. Sci. U.S.A. 79:4025–4029.
  • Zhu, Z., Veldman G. M., Cowie A., Carr A., Schaffhausen B., and Kamen R.. 1984. Construction and functional characterization of polyomavirus genomes that separately encode the three early proteins. J. Virol. 51:170–180.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.